Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain
Identifiers
URI: http://hdl.handle.net/20.500.12020/1934ISSN: 1560-7917
DOI: https://doi.org/10.2807/1560-7917.ES.2023.28.8.2200390
Author/s
Risco Risco, Carlos; Herrador, Zaida; López Perea, Noemí; Martínez Urbistondo, Diego; Suárez del Villar, Rafael; [et al.]Date
2023Document type
articleAbstract
A nationwide retrospective study based on the Spanish National Health System Hospital Discharge Database analysed 65,401 herpes zoster (HZ)-related hospitalisations between 1998 and 2018. The mean annual hospitalisation rate was 6.75 per 100,000 population, with a significant increasing trend over time, particularly in individuals aged ≥65 years. Male sex and immunocompromising conditions were associated with higher severity. Leukaemia/lymphoma and solid malignant neoplasm showed the highest adjusted risk ratios for readmission and mortality, while HIV infection was also independently associated with fatal outcome. This study establishes a national baseline prior to the progressive implementation of recombinant zoster vaccination in Spain, providing essential epidemiological data for future effectiveness assessments and public health planning.





